| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 32 |
| 1 | CAPECITABINE | 15 |
| 2 | ASPIRIN | 14 |
| 3 | RIVAROXABAN | 14 |
| 4 | ASPIRIN 325 MG | 11 |
| 5 | ASPIRIN 81 MG | 11 |
| 6 | CISPLATIN | 10 |
| 7 | BICALUTAMIDE | 9 |
| 8 | CANDESARTAN | 9 |
| 9 | FUROSEMIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MAGNESIUM SALICYLATE | 1 | 0.0017 |
| 1 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 2 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 3 | SENNOSIDES A AND B | 1 | 0.0006 |
| 4 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| 5 | BICALUTAMIDE | 9 | 0.0006 |
| 6 | MILK THISTLE | 1 | 0.0005 |
| 7 | LEUPROLIDE ACETATE | 32 | 0.0004 |
| 8 | ALFUZOSIN HYDROCHLORIDE | 1 | 0.0004 |
| 9 | ALFUZOSIN HCL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacyclin Receptor Agonist [EPC] | 7 | 0.0003 |
| 1 | Androgen Receptor Inhibitor [EPC] | 15 | 0.0002 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 4 | Platinum-based Drug [EPC] | 22 | 0.0001 |
| 5 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 6 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 19 | 0.0001 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 9 | 0.0001 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |